Cover Image

Sintilimab plus Anlotinib and Chemotherapy as First-line Treatment for Advanced Malignant Pleural Mesothelioma (SACH-MPM): A Prospective, Single-arm, Phase II Trial

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Author:	Huang, Yiyi
Format:	Recurso digital
Published:	Zenodo 2026
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of Neoadjuvant and Adjuvant Pleural Intensity‐Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma
by: Berta Mosleh, et al.
Published: (2025)

An Open‐Label, Single‐Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non‐Small Cell Lung Cancer After First‐Line PD ‐(L)1 Inhibitor
by: Xun Shi, et al.
Published: (2025)

Pleural Mesothelioma: Pathogenesis, Diagnosis, Treatment, Prognosis, and Survival
by: Libo Zhang, et al.
Published: (2025)

Pleural Fluid Cytology–Histology Correlation in Patients With Malignant Pleural Mesothelioma: A Series of 26 Cases
by: John Findley, et al.
Published: (2026)

Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview
by: Raffaella Pagliaro, et al.
Published: (2026)

Perfusion Strategies for Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma
by: Claire Drigotas, et al.
Published: (2024)

Clinical Significance of Bone Metastases in Pleural Mesothelioma
by: Mitsutomi Miyake, et al.
Published: (2025)

Multiscale Parallel Simulation of Malignant Pleural Mesothelioma via Adaptive Domain Partitioning -- an Efficiency Analysis Study
by: Dolganov, Anton, et al.
Published: (2025)

Remarkable Antitumor Effects and Serious Multiple Immune‐Related Adverse Events in Malignant Pleural Mesothelioma: Two Case Reports
by: Koharu Harada, et al.
Published: (2025)

A Rare Case of Akathisia After Removal of Subdural Hematoma During Treatment for Malignant Pleural Mesothelioma: Akathisia Induced by Brain Injury or Immune Checkpoint Inhibition
by: Tomomi Wada, et al.
Published: (2025)

Pembrolizumab With Anlotinib in Advanced Oral Mucosal Melanoma: A Retrospective Trial
by: Yun Bi, et al.
Published: (2026)

An Evaluation Into the Robustness of Grading of Pleural Mesothelioma Outside of Specialist Centres
by: Sarita Prabhakaran, et al.
Published: (2025)

Expert Consensus on the Diagnosis and Treatment of Malignant Mesothelioma of the Tunica Vaginalis Testis
by: Yiqing Cai, et al.
Published: (2025)

Two Cases of Diffuse Pleural Mesothelioma Discovered After Spontaneous Pneumothorax
by: Yuki Kato, et al.
Published: (2025)

Distant Metastatic Pattern and Its Prognostic Significance in Malignant Pleural Mesothelioma: A Population‐Based Study Based on a Machine Learning Model
by: Jian Yu, et al.
Published: (2025)

Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Single‐Arm Study
by: Xiaoyi Feng, et al.
Published: (2025)

Correction to “Integrating Polygenic and Methylation Risk Scores for Pleural Mesothelioma Risk Stratification”
Published: (2026)

Correction to “Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Single‐Arm Study”
Published: (2025)

Modeling Malignant Mesothelioma in Genetically Engineered Mice
by: Yuwaraj Kadariya, et al.
Published: (2025)

Radiotherapy‐Induced Pleural Mesothelioma in a Childhood Leukaemia Survivor: A Case Report
by: Sho Saeki, et al.
Published: (2025)

Efficacy and safety of Anlotinib in combination with gemcitabine and cisplatin as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma: A single‐arm clinical trial
by: Zhehao Xiao, et al.
Published: (2025)

Expression of Heart Development Protein With EGF‐Like Domains 1 (HEG1) Decorated With Low‐Sulfated Keratan Sulfate in Human Malignant Pleural Mesothelioma
by: Koki Nakashima, et al.
Published: (2025)

Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago‐gastric Diseases (PROCEED): A single‐arm phase 2 trial
by: Pooja Karukonda, et al.
Published: (2025)

Synchronous Pleural and Peritoneal Mesothelioma in a Free‐Ranging Capuchin Monkey (Sapajus libidinosus)
by: Isabel Luana de Macêdo, et al.
Published: (2024)

Psychosocial Needs of People Living With Pleural Mesothelioma and Family Carers: A Mixed Methods Study
by: Lauren J. Breen, et al.
Published: (2024)

Collaborative Indirect Treatment Comparisons with Multiple Distributed Single-arm Trials
by: Zhu, Yuru, et al.
Published: (2025)

Effects of Autophagy Inhibition by SAR405 , a Selective VPS34 Inhibitor, on Pleural Mesothelioma Cells
by: Yoshiki Kuwabara, et al.
Published: (2026)

Partial Response to Nivolumab and Ipilimumab in a Patient With Malignant Pleural Mesothelioma and Pre‐Existing Myasthenia Gravis Without Severe Flares or Immune‐Related Adverse Events: A Case Report
by: Mariko Higa, et al.
Published: (2025)

Docetaxel‐Induced Serositis Mimicking Malignant Pleural Effusion
by: Muhammad Anees, et al.
Published: (2026)

An Autopsy Case of Pleural Mesothelioma Progressed Rapidly With Multiple Organ Metastases During Immune Checkpoint Inhibitor Therapy
by: Mihoko Yamamoto‐Rikitake, et al.
Published: (2026)

Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine
by: Zu‐Yau Lin, et al.
Published: (2025)

Genetic and Immunohistochemical Profiling of Malignant Mesothelioma With Brain Metastasis: A Report of Two Cases
by: Paul M. Harary, et al.
Published: (2026)

Synergistic Sealing of the Pleural Space: Combining Thoracoscopic Talc Poudrage and IPC for Malignant Pleural Effusion—A Case Series
by: Mas Fazlin Mohamad Jailaini, et al.
Published: (2025)

Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for Evidence Evaluation and Recommendation
by: Shigeki Kusamura, et al.
Published: (2024)

GFM4MPM: Towards Geospatial Foundation Models for Mineral Prospectivity Mapping
by: Daruna, Angel, et al.
Published: (2024)

MPM Supera expectativas
Published: (2008)

Directorios MPM publicitarios
Published: (2004)

Pyrotinib and Nab‐Paclitaxel in HER2‐Positive Breast Cancer (PANHER Trial): A Prospective, Single‐Arm, Phase II Trial
by: Huan Li, et al.
Published: (2025)

Clinical Value of Patient‐Derived Tumor Organoids in Guiding Precision Chemotherapy for Locally Advanced Thyroid Cancer: A Single‐Center, Single‐Arm, Phase 2 Trial
by: Xixi Zhu, et al.
Published: (2026)

Primary Mediastinal Malignant Melanoma Presenting With Pleural Effusion: A Case Report
by: Minlian Nong, et al.
Published: (2026)